BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 38654165)

  • 1. Cuproptosis-related lncRNA signature as a prognostic tool and therapeutic target in diffuse large B cell lymphoma.
    Bai X; Lu F; Li S; Zhao Z; Wang N; Zhao Y; Ma G; Zhang F; Su X; Wang D; Ye J; Li P; Ji C
    Sci Rep; 2024 Jun; 14(1):12926. PubMed ID: 38839842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANXA5: A Key Regulator of Immune Cell Infiltration in Hepatocellular Carcinoma.
    Wang W; Liu D; Yao J; Yuan Z; Yan L; Cao B
    Med Sci Monit; 2024 Jun; 30():e943523. PubMed ID: 38824386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct cuproptosis patterns in hepatocellular carcinoma patients correlate with unique immune microenvironment characteristics and cell-cell communication, contributing to varied overall survival outcomes.
    Wang Y; Mang X; Guo X; Pu J
    Front Immunol; 2024; 15():1379690. PubMed ID: 38868777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of 10 differentially expressed and cuproptosis-related genes in immune infiltration and prognosis of thyroid carcinoma.
    Yu W; Liu H; Zhang Y; Liu M; Li W; Wang L; Li D
    Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):89-94. PubMed ID: 38650151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan-cancer analyses reveal molecular and clinical characteristics of cuproptosis regulators.
    Wu C; Tan J; Wang X; Qin C; Long W; Pan Y; Li Y; Liu Q
    Imeta; 2023 Feb; 2(1):e68. PubMed ID: 38868340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unraveling the intriguing interplay: Exploring the role of lncRNAs in caspase-independent cell death.
    Ciftci YC; Vatansever İE; Akgül B
    Wiley Interdiscip Rev RNA; 2024; 15(3):e1862. PubMed ID: 38837618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cuproptosis in cancers: Function and implications from bench to bedside.
    Huang XY; Shen JY; Huang K; Wang L; Sethi G; Ma Z
    Biomed Pharmacother; 2024 Jun; 176():116874. PubMed ID: 38850661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copper homeostasis and cuproptosis in gynecological disorders: Pathogenic insights and therapeutic implications.
    Lin Y; Yuan M; Wang G
    J Trace Elem Med Biol; 2024 Jul; 84():127436. PubMed ID: 38547725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel prognostic signature for lung adenocarcinoma based on cuproptosis-related lncRNAs: A Review.
    Di H; Zhao J; Zhu X; Zhou X; Hu Y; Wang M; Qiu Z; Zhang W; Chen X
    Medicine (Baltimore); 2022 Dec; 101(49):e31924. PubMed ID: 36626411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles and mechanisms of copper homeostasis and cuproptosis in osteoarticular diseases.
    Han J; Luo J; Wang C; Kapilevich L; Zhang XA
    Biomed Pharmacother; 2024 May; 174():116570. PubMed ID: 38599063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic analysis of hepatocellular carcinoma based on cuproptosis -associated lncRNAs.
    Wei M; Lu L; Luo Z; Ma J; Wang J
    BMC Gastroenterol; 2024 Apr; 24(1):142. PubMed ID: 38654165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel cuproptosis-related lncRNA signature predicts the prognosis and immunotherapy for hepatocellular carcinoma.
    Liu Y; Jiang J
    Cancer Biomark; 2023; 37(1):13-26. PubMed ID: 37005878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of cuproptosis-related lncRNAs for prognostic significance and immune microenvironment characterization in hepatocellular carcinoma.
    Li D; Jin S; Chen P; Zhang Y; Li Y; Zhong C; Fan X; Lin H
    Front Immunol; 2022; 13():991604. PubMed ID: 36685508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive analysis of cuproptosis-related lncRNAs in immune infiltration and prognosis in hepatocellular carcinoma.
    Liu C; Wu S; Lai L; Liu J; Guo Z; Ye Z; Chen X
    BMC Bioinformatics; 2023 Jan; 24(1):4. PubMed ID: 36597032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Cuproptosis-Related LncRNA Risk Model for Predicting Prognosis and Immunotherapeutic Efficacy in Patients with Hepatocellular Carcinoma.
    Wang S; Bai H; Fei S; Miao B
    Biochem Genet; 2023 Oct; ():. PubMed ID: 37898914
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.